Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. covers the month of November 2015, specifically dated November 18, 2015. The report details significant organizational restructuring within the executive management team and operational changes regarding share clearing and settlement on the Tel Aviv Stock Exchange (TASE).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and administrative updates rather than financial performance data.
Material Changes
Executive Management Restructuring
Effective immediately, the Company implemented the following changes to its executive team:
- Ido Dor: Appointed Executive Vice President & General Manager Crop Enhancement.
- Eran Kosover: Appointed Executive Vice President & General Manager Crop Protection.
- Dr. Hagai Karchi: Appointed Chief Technology Officer (CTO) and Head of R&D Crop Enhancement.
- Dr. Eyal Emmanuel: Appointed Chief Science Officer (CSO) and Head of R&D Crop Protection.
- Assaf Kacen: Appointed Chief Operation Officer (COO).
- Assaf Oron: Appointed Executive Vice President Corporate Development.
Share Clearing and Settlement
Effective November 2015, the clearing and settlement of all transactions in the Company's ordinary shares on the TASE will be handled exclusively by American Stock Transfer & Trust Company, LLC (AST). This replaces the previous arrangement with the registry company of Bank Leumi.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, outlook projections, or a discussion of risks and contingencies. The management commentary is limited to the announcement of the organizational changes and the rationale for the new share clearing agent to facilitate trading for dual-listed companies.
Key Facts for Investor Verification
- Verify the specific impact of the new executive appointments on the Company's strategic direction for Crop Enhancement and Crop Protection.
- Confirm the operational transition of TASE share clearing to American Stock Transfer & Trust Company, LLC.
- Note that this filing does not include Q3 2015 financial results; investors should refer to the separate Q3 2015 earnings release for financial metrics.